Retrospective examination to evaluate the information of pathological and prognosis after treatment of patients. The ancillary study of the trial "sentinel lymph node biopsy using ICG observation method in laparoscopic gastrectomy for gastric cancer and oesophageal gastric junction cancer.

Retrospective examination to evaluate the information of pathological and prognosis after treatment of patients. The ancillary study of the trial "sentinel lymph node biopsy using ICG observation method in laparoscopic gastrectomy for gastric cancer and oesophageal gastric junction cancer. - Ancillary investigation on pathological information and prognosis of patients who have undergone sentinel lymph node biopsy by ICG fluorescence observation method

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046843

Enrollment

517

Registered

2022-02-08

Start date

2021-05-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer and oesophageal gastric junction cancer.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who enrolled in "feasible study of sentinel lymph node biopsy using ICG fluorescence observation method for gastric and oesophageal gastric junction cancer".

Exclusion criteria

Exclusion criteria: History of laparotomy, body mass index >=30, Type 4 or 5 gastric cancer, previous or other concomitant cancer, a renal, hepatic, or metabolic disorder, cardiac disease, and a history of gastrectomy.

Design outcomes

Primary

Measure	Time frame
The detection rate of ICG marking and the rate of negative infiltration to the oesophageal and gastric resection line.	—

Secondary

Measure	Time frame
The adverse events related to ICG injection, the length of proximal margin, the perioperative outcomes, including operating time, estimated blood loss, postoperative mortality, morbidity, and postoperative hospital stay.	—

Countries

Japan

Contacts

Public ContactHisashi Hara

Osaka International Cancer Institute Department of Gastroenterological Surgery

hisashi.hara@oici.jp066945118

Outcome results